Analysis of the pharmacological action mechanism and therapeutic principle of eflornithine (IWILFIN)

Eflornithine (IWILFIN) is a new anti-tumor drug mainly used for the treatment of a variety of solid tumors and hematological malignancies. The drug inhibits tumor cell proliferation and induces apoptosis by targeting the nucleoside metabolism and DNA synthesis pathways of cancer cells. Compared with traditional chemotherapy drugs, eflornithine has higher selectivity and relatively low damage to normal cells, so it shows good tolerance in clinical applications.

The main mechanism of action of eflornithine is to interfere with the synthesis of cancer cells' DNA and RNA by simulating pyrimidine nucleotides. Specifically, it is metabolized into active nucleoside analogues in cells and incorporated into DNA or RNA chains, leading to interruption of chain elongation or accumulation of mutations, making tumor cells unable to replicate and divide normally. In addition, eflornithine can also inhibit the activity of key enzymes, such as thymidylate synthase, thereby further blocking the DNA synthesis pathway.

The therapeutic principle of eflornithine is based on the high proliferation characteristics of tumor cells. Cancer cells are highly dependent on the synthesis of DNA and RNA, and eflornithine can specifically interfere with these processes, thereby selectively inhibiting tumor growth. Compared with conventional chemotherapy, it has less impact on normal cells and can reduce the risk of bone marrow suppression and gastrointestinal adverse reactions. In addition, eflornithine can be used in combination with other targeted drugs or immunotherapy to achieve synergistic anti-cancer effects and improve the overall efficacy of treatment.

In clinical practice, eflornithine has shown good efficacy in lung cancer, colorectal cancer and certain hematological tumors. Future studies will further optimize the dosage regimen, explore combination drug strategies, and evaluate its long-term safety and resistance mechanisms. Through an in-depth understanding of the pharmacological mechanism of action, eflornithine is expected to become one of the standard treatment options for a variety of malignant tumors, providing patients with more precise and safe anti-cancer options.

Reference link:https://www.drugs.com